Platelet activation in Helicobacter pylori-associated idiopathic thrombocytopenic purpura: Eradication reduces platelet activation but seldom improves platelet counts

Acta Haematologica

Volumn 116, Issue 1, 2006, Pages 19-24

  Ahn, Eugene R ^a   Tiede, Maike P ^a   Jy, Wenche ^a   Bidot, Carlos J ^a   Fontana, Vincenzo ^a   Ahn, Yeon S ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

CD62p; Helicobacter pylori; Idiopathic thrombocytopenic purpura; P Selectin; Platelet activation

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; DANAZOL; LANSOPRAZOLE; PADGEM PROTEIN; PREDNISONE; RITUXIMAB; VINCRISTINE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BREATH ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ERADICATION THERAPY; FEMALE; FLOW CYTOMETRY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INFECTION; MALE; PRIORITY JOURNAL; SEROLOGY; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

ADULT; AGED; ATHEROSCLEROSIS; BREATH TESTS; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; P-SELECTIN; PLATELET ACTIVATION; PLATELET COUNT; PROSPECTIVE STUDIES; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 33745588616     PISSN: 00015792     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092343     Document Type: Article

References (25)

1. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G: Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878.
2. Emilia G, Longo G, Luppi M, Gandini G, Morselli M, Ferrara L, Amarri S, Cagossi K, Torelli G: Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic pupura. Blood 2001;97:812-814.
3. Kohda K, Kuga T, Kogawa K, Kanisawa Y, Kazuhiko K, Kuroiwa G, Hirayama Y, Sato Y, Matsunaga T, Niitsu Y: Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol 2002;118:588.
4. Ando K, Shimamoto T, Tauchi T, Ito Y, Kuriyama Y, Gotoh A, Miyazav K, Kimura Y, Kawai T, Ohysashiki K: Can eradication for Helicobacter pylori really improve thrombocytopenia in idiopathic thrombocytopenic pupura? Our experience and a literature review. Int J Haematol 2003;77:239-244.
5. Hino M, Yamane T, Park K, Takubo T, Ohta K, Kitagawa S, Higuchi K, Arakawa T: Platelet recovery after eradication of Helicobacter pylori in patients with idiopathic thrombocytopenic purpura. Ann Hematol 2003;82:30-32.
6. Veneri D, Franchini M, Gottardi M, D'Adda M, Ambrosetti A, Krampera M, Zanetti F, Pizzolo G: Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura. Haematologica 2002;87:1177-1179.
7. Takahashi T, Yujiri T, Shinohara K, Inoue Y, Sato Y, Fujii Y, Okubo M, Zaitsu Y, Ariyoshi K, Nakamura Y, Nawata R, Oka Y, Shirai M, Tanizawa Y: Molecular mimicry of Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004;124:91-96.
8. Suzuki T, Matsushima M, Masui A, Watanabe K, Takagi A, Ogawa Y, Shirai T, Mine T: Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura - A randomized controlled trial. Am J Gastroenterol 2005;100:1265-1270.
9. Nomura S, Inami N, Kanazawa S: The effects of Helicobacter pylori eradication on chemokine production in patients with immune thrombocytopenic purpura. Eur J Haematol 2004;72:304-305.
10. Jarque I, Andreu R, Llopis I, De la Rubia J, Gomis F, Senent L, Jimenez C, Martin G, Martinez JA, Sanz GF, Ponce J, Sanz MA: Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol 2001;115:1002-1003.
11. Michel M, Cooper N, Jean C, Frissora C, Bussel JB: Does Helicobacter pylori initiate or perpetuate immune thrombocytopenic purpura? Blood 2004;103:890-896.
12. Ahn ER, Tiede M, Bidot CJ, Jy W, Yaniz M, Gonzalez M, Blaya M, Ahn YS: Eradication of Helicobacter pylori seldom improves platelet counts in chronic ITP. Presented at the 45th ASH meeting, Dec 9, 2003, San Diego. Blood 2003;102:297a.
13. Kowalski K: Helicobacter pylori infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary artherosclerotic plaque. J Physiol Pharmacol 2004;52:3-31.
14. Franceschi F, Leo D, Fini L, Santoliquido A, Flore R, Tondi P, Roccarina D, Nista EC, Cazzato AI, Lupascu A, Pola P, Silveri NG, Gasbarrini G, Gasbarrini A: Helicobacter pylori infection and ischaemic heart disease: an overview of the general literature. Dig Liv Dis 2005;37:301-308.
15. Elizalde JI, Gomez J, Panes J, Lozano M, Casadevall M, Ramirez J, Pizcueta P, Marco F, Rojas F, Granger DN, Pique JM: Platelet activation in mice and human Helicobacter pylori infection. J Clin Invest 1997;100:996-1005.
16. Byrne MF, Kerrigan SW, Corcoran PA, Atherton JC, Murray FE, Fitzgerald DJ, Cox DM: Helicobacter pylori binds von Willebrand factor and interacts with GPIb to induce platelet aggregation. Gastroenterology 2003;124:1846-1854.
17. Elizalde JI, Perez-Pujol S, Heras M, Sionis A, Casanovas N, Martorell T, Lozano M, Gonzalez J, Escolar G, Sanz G, Pique JM: Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes. Helicobacter 2004;9:681-689.
18. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, Blanchette VS, Bussel JB, Cines DB, Kelton JG, Lichtin AE, McMillan R, Okerbloom JA, Regan DH, Warrier I: Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
19. Jy W, Mao WW, Horstman LL, Valant PA, Ahn YS: A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT). Thromb Haemost 1998;82:1255-1259.
20. Van Doom LJ, Figueiredo C, Megraud F, Pena S, Midolo P, Queiroz DM, Carneiro F, Vanderborght B, Pegado MD, Sanna R, De Boer W, Schneeberger PM, Correa P, Ng EK, Atherton J, Blaser MJ, Quint WG: Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology 1999;116:823-830.
21. Evans DJ, Evans DG: Helicobacter pylori cagA: analysis of sequence diversity in relation to phosphorylation motifs and implications for the role of cagA as a virulence factor. Helicobacter 2001;6:187-198.
22. Merten M, Thiagarajan P: P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 2000;102:1931-1936.
23. Cassar K, Bachoo P, Ford F, McGee M, Greaves M, Brittenden J: Helicobacter pylori seropositivity is associated with enhanced platelet activation in patients with intermittent claudication. J Vasc Surg 2004;39:560-564.
24. Blann AD, Nadar SK, Lip GY: The adhesion molecule P-selectin and cardiovascular disease. Eur Heart J 2003;24:2166-2179.
25. Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S: Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 2003;73:232-241.